Trilaciclib (G1T28) in Patients With Previously Treated Extensive Stage SCLC Receiving Topotecan Chemotherapy
Phase 1b/2a Safety and Pharmacokinetic Study of G1T28 in Patients With Previously Treated Extensive Stage Small Cell Lung Cancer (SCLC) Receiving Topotecan Chemotherapy
Sponsor: G1 Therapeutics, Inc.
This PHASE1/PHASE2 trial investigates Small Cell Lung Cancer and is currently completed. G1 Therapeutics, Inc. leads this study, which shows 23 recorded versions since 2015 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
23 versions recorded-
Oct 2025 — Present [monthly]
Completed PHASE1/PHASE2
Status: Terminated → Completed
-
Sep 2025 — Oct 2025 [monthly]
Terminated PHASE1/PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jul 2022 — Jul 2024 [monthly]
Terminated PHASE1_PHASE2
Status: Active Not Recruiting → Terminated
▶ Show 18 earlier versions
-
Apr 2022 — Jul 2022 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Feb 2021 — Apr 2022 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Sep 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Mar 2020 — Sep 2020 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Sep 2019 — Mar 2020 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Aug 2019 — Sep 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jul 2019 — Aug 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
-
Jun 2018 — Jul 2019 [monthly]
Active Not Recruiting PHASE1_PHASE2
Status: Recruiting → Active Not Recruiting
-
Mar 2018 — Jun 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Dec 2017 — Mar 2018 [monthly]
Recruiting PHASE1_PHASE2
-
Aug 2017 — Dec 2017 [monthly]
Recruiting PHASE1_PHASE2
-
Jul 2017 — Aug 2017 [monthly]
Recruiting PHASE1_PHASE2
-
Jun 2017 — Jul 2017 [monthly]
Recruiting PHASE1_PHASE2
-
May 2017 — Jun 2017 [monthly]
Recruiting PHASE1_PHASE2
-
Mar 2017 — May 2017 [monthly]
Recruiting PHASE1_PHASE2
-
Feb 2017 — Mar 2017 [monthly]
Recruiting PHASE1_PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Oct 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- G1 Therapeutics, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .